Premarket Notification: Analysis of FDA Recall Data
|
|
- Erik Reed
- 6 years ago
- Views:
Transcription
1 Premarket Notification: Analysis of FDA Recall Data Director, Medical Device Safety Institute Beth Israel Deaconess Medical Center Boston, MA IOM 510(k) Workshop July 28, 2010
2 Disclosure FDA Consultant
3 Overview Background Overview of FDA 510(k) and Recall Databases Data Analysis Conclusions
4 Device Approval/Clearance Performance Measures IDEAL Device Reliability, Device Performance SURROGATE Regulatory Actions Recalls Medical Device Reports (MDRs) Other (Warning Letters, etc)
5 FDA Recall Definition A recall is an action taken to address a problem with a medical device that violates FDA law. Recalls occur when a medical device is defective, when it could be a risk to health, or when it is both defective and a risk to health. -U.S. Food and Drug Administration
6 Purpose of this Study Analyze FDA recall data affecting 510(k) products Provide estimate of 510(k) product recall rates Describe causes of recalls affecting 510(k) products Identify product risk factors for recall
7 Data Analysis 1996 FDA 510(k) Database FDA Recall 2009 Database
8 Annual # 510(k) Applications Total = 48,402 Range =
9 Advisory Committee Assignments for 510(k)s Submitted (k)s % ANCH CV DE EN GU HE HO IM MI NE OB OP OR PA PM RA SU TX
10 510(k) Device Classification %
11 510(k) Type % of Applications
12 510(k) Type
13 510(k) Features
14 Annual Number of Unique 510(k)s Affected by Recall
15 Number of Recalls per 510(k) Recalls per 510(k) # Occurrences Percentage of 510(k) Recalls >
16 Year of 510(k) Decision for Recalls Occurring %
17 Determining Recall Rate Accounting for Differential Follow-Up A B C D E Recall Recall Study End Study End Study End F Recall 01/01/03 12/31/09
18 Recall-Free 510(k) Survival Proportion Recall-Free YEARS SINCE 510(k) DECISION # at Risk: Survival:
19 Annual 510(k) Recall Rate Based on Years Since Decision Percent Recalled YEARS SINCE 510(k) DECISION
20 Causes of 510(k) Recalls Cause Description Recalls (%) Manufacturing Process Device Design Materials/ Components Change Control Employee Error Manufacturing process inadequately controlled, inadequate environmental controls, storage, packaging, labeling, equipment maintenance, material removal, etc. Failure of device to perform as intended despite meeting design specifications. Materials/components that are non-conforming, contaminated, degraded, counterfeit or inadequately tested. A change made to a specification, program, procedure, vendor, etc. that adversely affects a component, finished device, packaging, labeling, etc. Employee error (not a systematic problem). Usually corrected by retraining. Miscellaneous TOTAL
21 Number of Predicates 510(k) P for trend = 0.003
22 Number of Predicates 510(k) P for trend < AGE OLDEST PREDICATE
23 510(k) Type * P< % of Applications *
24 510(k) Features * * P<0.001 * * Review Office
25 510(k) Features * P<0.001 *
26 510(k) Device Classification % * P<0.001 * *
27 Advisory Committee Assignments for 510(k)s Submitted % No Recall Recall % AN CH CV DE EN GU HE HO IM MI NE OB OP OR PM RA SU TX
28 Medical Device Reporting and 510(k)s Description Number 510(k)s with MDR 7823 Total MDRs MDRs with Death 2361 MDRs with Injury MDRs with Malfunction MDRs Other 5051
29 Medical Device Reporting and Recalls
30 Summary of Key Findings 1. More than 3000 devices are cleared for marketing each year under new 510(k)s. Overall, there have been more than 48, (k)s since Recalls affect 510(k) devices times annually. 3. The annual rate of recall for 510(k) products is ~ % per year for the first 4 years post clearance; the rate falls to ~ 1.0% for postmarket years Manufacturing process and device design issues are the most common causes cited for 510(k) recalls. 5. A large number of predicates, special 510(k)s, 3 rd party reviews, and life-sustaining devices are associated with a higher rate of recall.
31 Acknowledgments FDA Ann Ferriter Shawn Forrest Eugene Reilly Gerry Gray IOM Heather Colvin Abigail Mitchell
Using Recall Data to Assess the 510(k) Process
Using Recall Data to Assess the 510(k) Process Ralph F. Hall Distinguished Professor and Practitioner University of Minnesota Law School July 28, 2010 Acknowledgments 2 Disclosures 3 Agenda I. Research
More informationPublic Health Service Food and Drug Administration San Francisco District 1431 Harbor Bay Parkway Alameda, CA Telephone: 510/
Department of Health and Human Services Public Health Service Food and Drug Administration San Francisco District 1431 Harbor Bay Parkway Alameda, CA 94502-7070 Telephone: 510/337-6700 WARNING LETTER December
More informationMedical Device Recall Report FY2003 to FY2012
Medical Device Recall Report FY2003 to FY2012 Food and Drug Administration Center for Devices and Radiological Health Office of Compliance Division of Analysis and Program Operations 1 1. Executive Summary
More informationUse of Standards in Substantial Equivalence Determinations
Guidance for Industry and for FDA Staff Use of Standards in Substantial Equivalence Determinations Document issued on: March 12, 2000 U.S. Department Of Health And Human Services Food and Drug Administration
More information510(k) submissions. Getting US FDA clearance for your device: Improving
Getting US FDA clearance for your device: Improving 510(k) submissions Audrey Swearingen, RAC Director, Regulatory Affairs Telephone: +1 512.222.0263 Email: aswearingen@emergogroup.com Download this white
More information2/17/2018. Prof. Steven S. Saliterman Department of Biomedical Engineering, University of Minnesota
Department of Biomedical Engineering, University of Minnesota http://saliterman.umn.edu/ FDA Authority Medical Device Act of 1976 FDA Modernization Act of 1997 Federal Food, Drug and Cosmetic Act (FFDCA)
More informationProf. Steven S. Saliterman. Department of Biomedical Engineering, University of Minnesota
Department of Biomedical Engineering, University of Minnesota http://saliterman.umn.edu/ FDA Authority Medical Device Act of 1976 FDA Modernization Act of 1997 Federal Food, Drug and Cosmetic Act (FFDCA)
More informationSeptember 28, Division of Dockets Management (HFA-305) Food and Drug Administration 5630 Fishers Lane, Room 1061 Rockville, MD 20852
September 28, 2011 Division of Dockets Management (HFA-305) Food and Drug Administration 5630 Fishers Lane, Room 1061 Rockville, MD 20852 Re: Docket No. : Center for Devices and Radiological Health 510(k)
More informationPreparing a US FDA Medical Device 510(K) Submission
Preparing a US FDA Medical Device 510(K) Submission If you want to introduce your medical device to the US market, you need to obtain clearance from the FDA. This clearance is obtained from the FDA via
More informationComments of the Patient, Consumer, and Public Health Coalition. Strengthening the Center for Devices and Radiological Health s 510(k) Review Process
March 19, 2010 Division of Dockets Management (HFA-305) Food and Drug Administration 5630 Fishers Lane, Room 1061 Rockville, MD 20852 Comments of the Patient, Consumer, and Public Health Coalition on Strengthening
More informationStonegate Pharmacy LP 11/10/16
Stonegate Pharmacy LP 11/10/16 November 10, 2016 2017 DAL WL 03 WARNING LETTER UPS Overnight Rene F. Garza, Pharm.D., Chief Executive Officer Stonegate Pharmacy, LP 2501 W. William Cannon Drive, Suite
More informationMedidée Services SA. Nano-Tera.ch. 05 February 2015 part 4. Intro ISO GMP - GLP Pierre-Alain Sommer
Nano-Tera.ch 05 February 2015 part 4 Intro ISO GMP - GLP Pierre-Alain Sommer Pierre-alain.sommer@medidee.com www.medidee.com Nano-Tera 2015 05.02.2015 Introduction to ISO 13485, cgmp s and GLP s Context
More informationAFDO Conference June 9, Mercedes Mota, Director Medical Device, Surgical Care Johnson & Johnson Quality & Compliance Worldwide
AFDO Conference June 9, 2009 Mercedes Mota, Director Medical Device, Surgical Care Johnson & Johnson Quality & Compliance Worldwide Government Agencies 483 observations A violation of the FD&C Act involving
More informationEstablishing Rules for: Medical Device Reports (803) & Correction and Removal Reports (806)
Establishing Rules for: Medical Device Reports (803) & Correction and Removal Reports (806) Presented by: Cap Uldriks, FDA Daniel P. Olivier, CCS Page 1 Objectives Define regulatory reporting rules based
More informationFDA 510(k) 101 The Basics
FDA 510(k) 101 The Basics Floyd G. Larson President, PaxMed International San Diego, CA OMTEC June 17, 2010 Chicago Agenda History of 510(k) process FDA s risk based approach FDA guidance and standards
More informationTown and Country Compounding and Consultation Services, LLC 10/17/17
Town and Country Compounding and Consultation Services, LLC 10/17/17 Division of Pharmaceutical Quality Operations I 10 Waterview Blvd, 3rd FL Parsippany, NJ 07054 Telephone: (973) 331-4900 FAX: (973)
More informationTSDR Pharmacy Inc. dba brandmd Skin Care 11/9/17
TSDR Pharmacy Inc. dba brandmd Skin Care 11/9/17 Division of Pharmaceutical Quality Operations IV 19701 Fairchild, Irvine, CA 92612-2506 Telephone: 949-608-2900 Fax: 949-608-4417 WARNING LETTER VIA SIGNATURE
More informationKo0 -t. Exhibit 2 MAY 3 0? 510 (K) Summay. Company Name: Columbia Scientific Development, LLC 420 NW I Ith Ave., Suite 617 Portland, Oregon 97209
Ko0 -t Exhibit 2 MAY 3 0? 510 (K) Summay Company Name: Columbia Scientific Development, LLC 420 NW I Ith Ave., Suite 617 Portland, Oregon 97209 Contact: Stephen Shulman Phone: 734-663-0132 Fax: 734-663-1306
More informationCenter for Devices & Radiological Health: Lifecycle Products. Laura Marquart, MD, FAAD
Center for Devices & Radiological Health: Lifecycle Products Laura Marquart, MD, FAAD 1 AAD FDA Symposium: Medical Devices The intent of this presentation is to present in brief specific actions by FDA
More information4/26/2013. Libia Lugo Drug Specialist San Juan District Office Investigations Branch
Libia Lugo Drug Specialist San Juan District Office Investigations Branch The Food and Drug Administration (FDA) responsibilities extend to the 50 United States, the District of Columbia, Puerto Rico,
More informationFood and Drug Law. Fall Syllabus. Professor Jesson. Hamline University School of Law
Food and Drug Law Fall 2009 Syllabus Professor Jesson Hamline University School of Law General course Information: Course: Food and Drug Law Credits: 2 Classroom: Law 103 Time: Thursdays, 4-5:50 p.m. Professor:
More information5101K] SUMMARY [as required by (c)]
735-10, Ancheong-dong, Gwangsan-gu, Gwangju, Korea FAX:+82-62-954-1055 http://www. inarex. co. kr IN AR E)( TEL:+82-62-952-1052 INAREX CORPORATION 5101K] SUMMARY [as required by 807.92(c)] AUG 2 7 2008
More informationTobacco Product Applications: FDA Perspective
Tobacco Product Applications: FDA Perspective Matthew R. Holman, Ph.D. Director, Office of Science Center for Tobacco Products Disclaimer: This information is not a formal dissemination of information
More informationMini Summit XIV: Clinical Trial Disclosure and Results Reporting Liability under FDAAA, Section 801
Mini Summit XIV: Clinical Trial Disclosure and Results Reporting Liability under FDAAA, Section 801 Jarilyn Dupont, JD Director of Regulatory Policy, Office of Policy Office of Commissioner, U.S. Food
More informationcgmp (21 CFR 111) Regulation and Compliance Overview
cgmp (21 CFR 111) Regulation and Compliance Overview Neogen Effective Compliance Seminar September 23, 2014 Michael McGuffin President, American Herbal Products Association mmcguffin@ahpa.org Regulation
More informationOverview of the Legal Framework for Medical Device Regulation in the United States
1 Overview of the Legal Framework for Medical Device Regulation in the United States Ellen J. Flannery This chapter provides an overview of the legal framework for medical device regulation in the United
More informationFDA Regulation of Diagnostic Tests Jeffrey N. Gibbs Hyman, Phelps & McNamara, P.C. Washington, DC
AIPLA Annual Meeting Joint Biotechnology Committee/ Special Committee on FDA Law Program October 21, 2010 Marriott Wardman Park Hotel Washington, DC FDA Regulation of Diagnostic Tests Jeffrey N. Gibbs
More informationOverhauling The 510(k) Process
Portfolio Media. Inc. 860 Broadway, 6th Floor New York, NY 10003 www.law360.com Phone: +1 646 783 7100 Fax: +1 646 783 7161 customerservice@law360.com Overhauling The 510(k) Process Law360, New York (August
More informationBEST PRACTICE CHANGE CONTROL : DECIDING WHEN TO SUBMIT A 510(K) FOR A DEVICE CHANGE. Yuan Xu 18- JAN- 2018
BEST PRACTICE CHANGE CONTROL : DECIDING WHEN TO SUBMIT A 510(K) FOR A DEVICE CHANGE Yuan Xu 18- JAN- 2018 Background AGENDA What is Medical Device? What is 510(k)? Principles of best practices of device
More informationPFC Training Courses & Programs. Course Descriptions. 1. Core Cannabis Training (CCT) [pre-requisite for all PFC Courses]
PFC Training Courses & Programs Core Cannabis Training (CCT) National Cannabis Standards Courses (NCST) State Specific Compliance Training (SSCT) PFC Enrichment Courses (PFCEC) PFC Verified Professional
More informationFDLI s Enforcement, Litigation, and Compliance Conference. Center for Tobacco Products Office of Compliance and Enforcement 2017 Update
FDLI s Enforcement, Litigation, and Compliance Conference Center for Tobacco Products Office of Compliance and Enforcement 2017 Update Ann Simoneau, Director Office of Compliance and Enforcement Center
More informationOverview of Dietary Supplement GMP Inspection Trends Quality Session 6
Overview of Dietary Supplement GMP Inspection Trends Quality Session 6 Presented by: Dean R. Cirotta, MBA President & Chief Operating Officer EAS Consulting Group, LLC 1700 Diagonal Road, Suite 750 Alexandria,
More informationMedical Devices and the Public s Health: The FDA 510(k) Clearance Process at 35 Years. Written Statement of
Medical Devices and the Public s Health: The FDA 510(k) Clearance Process at 35 Years Written Statement of Dr. David R. Challoner Vice President for Health Affairs, Emeritus University of Florida and Chair,
More informationCDRH: 510(k)S AND SCIENCE IN REGULATOR DECISION-MAKING. lannery, Scott Danzis and Christopher Pruitt. November 2010 SPECIAL REPRINT
November 2010 SPECIAL REPRINT CDRH: 510(k)S AND SCIENCE IN REGULATOR ORY DECISION-MAKING By Ellen Flanner lannery, Scott Danzis and Christopher Pruitt Reproduced with the kind permission of Global Regulatory
More informationSAMED Position: Reuse of SUDs
SAMED Position: Reuse of SUDs What We Will Cover SAMED - who we are and what we do Definition of single-use device Overview of single-use device reprocessing Overview of SA and other countries regulatory
More informationAKA Good Manufacturing Practice (GMP) Certification Program
AKA Good Manufacturing Practice (GMP) Certification Program Preamble The American Kratom Association (AKA) is establishing this program to assure the safety and integrity of kratom dietary supplements
More informationRegulatory Experience in Reviewing CV Safety for Diabetes
Regulatory Experience in Reviewing CV Safety for Diabetes Drugs Kristina Dunder MD, PhD, Alternate CHMP member MPA, Sweden Disclaimer The views and opinions expressed in the following PowerPoint slides
More informationRECALL / EVENT INVESTIGATION & PATIENT LOOK BACK
RECALL / EVENT INVESTIGATION & PATIENT LOOK BACK Federal, State and AABB requirements for nonconforming product investigation and recipient look back for adverse impact Stacy Ralston MPH, CLS (ASCP), RAC
More informationMedical Device Approval and Product Recalls
Medical Device Approval and Product Recalls Presented by Sean P. Farley, MBA, CMRP Director, Organizational Procurement Virginia Mason Medical Center President, WSHMMA - Introduction and the Business Environment
More informationSan Diego Compounding Pharmacy 9/25/17
San Diego Compounding Pharmacy 9/25/17 Division of Pharmaceutical Quality Operations IV 19701 Fairchild Road Los Angeles, CA 92612 WARNING LETTER VIA UNITED PARCEL SERVICE SIGNATURE REQUIRED September
More informationCDER Compliance Update
CDER Compliance Update Donald D. Ashley, JD 22 nd Annual GMP by the Sea August 30, 2017 www.fda.gov www.fda.gov 2 Office of Compliance Structure Office of Compliance Office of Drug Security, Integrity
More informationDonald W. Guthner Orgenix, LLC Ill Hill Road. Douglassville, PA (888) ORGENIX ( ) (484) (FAX) Intramedullary Nails, Nails
K070741 ~, SANATMETAL Manufacturer of Orthopaedic and Traumatologic Products H-3301, Eger Faiskola ut 5. Phone: +(36)36-512-900 Fax: +(36)36-512-932 e-mail: metalasanatmetal.hu 510(k) Statement of Summary
More informationSafety Evaluation for Substances Directly Added to Food
Safety Evaluation for Substances Directly Added to Food Teresa Croce, PhD Office of Food Additive Safety Center for Food Safety and Applied Nutrition US Food and Drug Administration How Does FDA Regulate
More informationInspections, Compliance, Enforcement, and Criminal Investigations
Page 1 of 9 Inspections, Compliance, Enforcement, and Criminal Investigations Phoenix Medical Devices, LLC 9/29/2009 Department of Health and Human Services Public Health Service Food and Drug Administration
More informationBacterin International Incorporated Mr. Howard L. Schrayer 600 Cruiser Lane Belgrade, Montana August 18, 2015
DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service Food and Drug Administration 10903 New Hampshire Avenue Document Control Center WO66-G609 Silver Spring, MD 20993-0002 Bacterin International
More informationChanges to the Eighth Edition
Pharmacy Practice and the Law, Eighth Edition Includes Navigate 2 Advantage Access By Richard R. Abood, BS Pharm, JD-Professor Emeritus Pharmacy Practice, Thomas J. Long School of Pharmacy and Health Sciences,
More informationIntroduction. Current status of 510(k) clinical data requirements. 1 Current Status&Considerations:
510(k) Current Status&Considerations: Conducting a Well-Controlled Clinical Study When Clinical Data is Required Introduction In an effort to promote innovation while protecting the population at large,
More informationTalon Compounding Pharmacy 10/3/17
Talon Compounding Pharmacy 10/3/17 Office of Pharmaceutical Quality Operations, Division II 4040 N. Central Expressway, Suite 300 Dallas, Texas 75204 October 3, 2017 CMS Case # 522630 VIA UPS EXPRESS WARNING
More informationBetter Health Lab, Inc 2/18/15
U.S. Food and Drug Administration Protecting and Promoting Your Health Better Health Lab, Inc 2/18/15 Department of Health and Human Services Public Health Service Food and Drug Administration New Jersey
More informationCDER Compliance Update
CDER Compliance Update Douglas Stearn, JD Deputy Director for Policy and Analysis FDA/CDER/Office of Compliance FDLI Enforcement, Litigation and Compliance Conference Washington, DC December 12, 2012 1
More informationJuly 10, X-spine Systems, Incorporated David Kirschman, MD Chief Medical Officer 452 Alexandersville Road Miamisburg, Ohio 45342
DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service July 10, 2015 Food and Drug Administration 10903 New Hampshire Avenue Document Control Center WO66-G609 Silver Spring, MD 20993-0002 X-spine
More informationJanuary 7, Dear Ms. Chung:
DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service Food and Drug Administration 10903 New Hampshire Avenue Document Control Center WO66-G609 Silver Spring, MD 20993-0002 January 7, 2015 Jeisys
More informationFood Safety Regulation Chapter One Definitions
Food Safety Regulation Chapter One Definitions Article (1): In the application of the provisions of these regulations, words and terms herein shall have the meanings stated in Food Safety Law. The following
More informationSchools Hearings & Appeals Procedure
Schools Hearings & Appeals Procedure Status: Updated October 2016. The following procedures will apply when cases are referred to Hearings and Appeals; Contents: Page Hearings 2 Appeals 2 The role of HR
More informationKey CDRH Regulatory Initiatives
Key CDRH Regulatory Initiatives Revamping the Submission Process Creating New Strategies Ralph F. Hall University of Minnesota Law School Counsel Faegre Baker & Daniels May 8, 2012 Purpose of Today s Program
More informationMarch 8, DxNow, Inc. Kevin Sly Senior Advisor to DxNow, Inc. 401 Professional Drive, Suite 130 Gaithersburg, Maryland
March 8, 2018 Kevin Sly Senior Advisor to 401 Professional Drive, Suite 130 Gaithersburg, Maryland 20879-3429 Re: Trade/Device Name: ZyMot ICSI Sperm Separation Device, ZyMot Multi Sperm Separation Device
More informationPublic Health Service Food and Drug Administration Dallas District 4040 North Central Expressway Dallas, Texas
Department of Health and Human Services Public Health Service Food and Drug Administration Dallas District 4040 North Central Expressway Dallas, Texas 75204-3128 March 30, 2010 2010-DAL-WL-08 CERTIFIED
More informationNEURONETICS. 510(k) SUMMARY NEUROSTAR TMS THERAPY SYSTEM'
NEURONETICS 510(k) SUMMARY NEUROSTAR TMS THERAPY SYSTEM' 510(k) Owner: Neuronetics, Inc. DEC 1 6 Z008 1 Great Valley Parkway, Suite 2 Malvern, PA 19355 Phone: 610-640-4202 Fax: 610-640-4206 Company Contact:
More informationDistillers Grains Symposium
Distillers Grains Symposium REGULATORY ISSUES/FSMA IMPACTS ON PRODUCTION & SALE OF DDGS Leah Wilkinson American Feed Industry Association lwilkinson@afia.org Dallas, TX May 15, 2014 Topics to be Presented
More informationDIRECTIVES. (Text with EEA relevance)
L 238/44 DIRECTIVES COMMISSION DIRECTIVE (EU) 2017/1572 of 15 September 2017 supplementing Directive 2001/83/EC of the European Parliament and of the Council as regards the principles and guidelines of
More informationIn Vitro Diagnostic Testing for Direct Oral Anticoagulants- Premarket Review
In Vitro Diagnostic Testing for Direct Oral Anticoagulants- Premarket Review Cardiac Safety Research Consortium December 3, 2015 Lea Carrington Division of Immunology and Hematology Devices Office of In
More informationRegulatory Submission Strategies and Outlines For Ultrasonic Surgical Devices: Contact and HIFU Systems UIA Symposium Ronald R.
Regulatory Submission Strategies and Outlines For Ultrasonic Surgical Devices: Contact and HIFU Systems 2006 UIA Symposium Ronald R. Manna Regulation Governing Medical Devices Europe: Council Directive
More informationtens_(transcutaneous_electrical_nerve_stimulator) 7/ / / /2014 This policy is NOT effective until January 13, 2015
Corporate Medical Policy TENS (Transcutaneous Electrical Nerve Stimulator) File Name: Origination: Last CAP Review: Next CAP Review: Last Review: tens_(transcutaneous_electrical_nerve_stimulator) 7/1982
More informationOverview of FDA Oversight and Enforcement on Drug Compounding
Overview of FDA Oversight and Enforcement on Drug Compounding Ruey Ju, Pharm.D., J.D. Senior Advisor for Compounding Compliance and Enforcement (Acting) Center for Drug Evaluation and Research Today s
More informationPIC/S GUIDANCE ON CLASSIFICATION OF GMP DEFICIENCIES
PHARMACEUTICAL INSPECTION CONVENTION PHARMACEUTICAL INSPECTION CO-OPERATION SCHEME PI 040-1 3 Appendices 1 January 2019 PIC/S GUIDANCE ON CLASSIFICATION OF GMP DEFICIENCIES PIC/S January 2019 Reproduction
More informationMark M. Yacura. Partner
Mark M. Yacura Partner Mark M. Yacura focuses his practice primarily on FDA legal and regulatory matters. He has practiced in this area for more than 30 years. He represents his clients before administrative
More informationThe Basics of the U.S. FDA s Regulation of Materials Used in Food Packaging Applications
The Basics of the U.S. FDA s Regulation of Materials Used in Food Packaging Applications RadTech UV & EB Technology Expo & Conference 2012 Presented by David J. Ettinger Partner Keller and Heckman LLP
More informationPlanning For The FDA s 'Deeming Rule' For E- Cigarettes
Law360, New York (September 21, 2015, 3:39 PM ET) -- The 2009 Family Smoking Prevention and Tobacco Control Act (TCA)[1] gave the U.S. Food and Drug Administration the authority to oversee the manufacture,
More informationIndustry s Perspective on the Status of Medical Device Regulations. FUNDISA Workshop 09 & 10 Oct Anele Vutha SAMED Regulatory Committee
Industry s Perspective on the Status of Medical Device Regulations FUNDISA Workshop 09 & 10 Oct 2014 Anele Vutha SAMED Regulatory Committee Today s Topics: 1. Medical Device Definition - Differences 2.
More informationPacemaker and ICD Generator Malfunctions
ORIGINAL CONTRIBUTION Pacemaker and ICD Generator Malfunctions Analysis of Food and Drug Administration Annual Reports William H. Maisel, MD, MPH Megan Moynahan, MS Bram D. Zuckerman, MD Thomas P. Gross,
More information510(k) 21 Summary of Safety and Effectiveness
510(k) 21 Summary of Safety and Effectiveness This summary of 510(k) safety and effectiveness information is being submitted in accordance with the requirement of 21 CFR 807.92. Submitter's Identification:
More information510(K) SUMMARY. Ventus Medical, Inc Shoreway Road, Suite 340 Belmont, CA Menlo Park, CA (650) (phone) (650) (fax)
510(K) SUMMARY 510(k) Applicant: Contact: Ventus Medical, Inc. 1301 Shoreway Road, Suite 340 Belmont, CA 94002 Menlo Park, CA 94025 (650) 632-4199 (phone) (650) 632-4198 (fax) Cindy Domecus, R.A.C. (US
More informationF DA 'ac/0 --tii -oas SIEMENS. Sincerely, March 5, 2010
SIEMENS March 5, 2010 Division of Dockets Management (HFA-305) Food and Drug Administration 5630 Fishers Lane, Rm. 1061 Rockville, MD 20852 Re : Docket No. FDA-2010-N-0054. Strengthening the Center for
More informationDavid L. Rosen, B.S. Pharm., J.D. Partner, Adv. and FDA Regulatory Practice Co-chair, Life Sciences Industry Team Washington, DC
SUCCESSFULLY DEALING WITH BUSINESS, REGULATORY AND IP CHALLENGES IN ISRAELI BIOMED COMPANIES: Current FDA Issues Impacting the Regulation of BioMed Companies David L. Rosen, B.S. Pharm., J.D. Partner,
More informationSandoz Inc. 12-Aug-08
Sandoz Inc. 12-Aug-08 Department of Health and Human Services Public Health Service Food and Drug Administration Atlanta District Office 60 8th Street, N.E. Atlanta, Georgia 30309 August 12, 2008 VIA FEDERAL
More informationOverview of Regulatory Science of Food Contact Substances
Overview of Regulatory Science of Food Contact Substances Michael A. Adams, PhD Deputy Director, Office of Food Additive Safety FDA, Center for Food Safety and Applied Nutrition 5001 Campus Drive, College
More informationThe Challenge of Treating Pain
FDA Charge to the Committee: FDA Opioid Action Plan and Incorporating the Broader Public Health Impact into the Formal Risk-Benefit Assessment for Opioids Robert M. Califf, MD Commissioner of Food and
More informationGuidelines for the Recall or Withdrawal of a Medical Product
National Drug Authority Rumee Towers Plot 19, Lumumba Avenue P. O. Box 23096 Kampala, Uganda. Tel: +256-0414 - 255665/347391/2 E-mail: ndaug@nda.or.ug Website: http://www.nda.or.ug TABLE OF CONTENTS 0.2
More informationATTACHMENT A AdvaMed Comments Draft-Guidance for Industry and FDA Staff -510(k) Modifications: Deciding When to Submit a 510(k) for a Change to an Existing Device Line(s) No. Line or lines numbers of the
More informationSECTION 2. SUMMARY AND CERTIFICATIOIov
SECTION 2. SUMMARY AND CERTIFICATIOIov 1 4 2 00 8 A. 510(K) SUMMARY.Summary of Safetv and Effctiveness In accordance with 21 CFR 807.92, the following information constitutes the Oticon Medical summary
More informationko~ Tk (K) SUMMARY
ko~3367-3 13. 510(K) SUMMARY 7-Tk 1 92006 Mega'Gen Co., Ltd. 114-8, Eupchun-Ri, Jain-Myun, Gyeongsan, Gyeongbuk South Korea Phone: 82-53-857-5770, Fax: 82-53-857-5432 510(K) Summary 510O(K) SUMMARY AND
More informationMedical Device Regulatory Decision Points
Medical Device Regulatory Decision Points Medical Device Classification Benefit Risk Regulatory Path Predicate Devices Valid Scientific Evidence Least Burdensome Approach Medical Devices Classified by
More informationK Michael Kolber Regulatory Affairs
510(k) Number Submitter Name and Address Name: Contact: Address: Consultant, K122105 for the SM I Cardiovascular Patch November 7, 2012 Appendix 4: 510(k) Summary per (21CFRSO7.92) DEC 1 202 K122105 Michael
More informationBest Practices in FDA 483 and Warning Letter Management and Recovery
Best Practices in FDA 483 and Warning Letter Management and Recovery Elaine C. Messa, RAC Director, Medical Device Quality Systems and Compliance Practice This document is intended to facilitate an oral
More informationThe Tobacco Control Act s Premarket Review Authorities: Reports on Substantial Equivalence and Exemption Requests (905(j))
The Tobacco Control Act s Premarket Review Authorities: Reports on Substantial Equivalence and Exemption Requests (905(j)) January 12, 2011 Cristi Stark, MS Senior Regulatory Health Project Manager Office
More informationBill. amending the Tobacco Control Act, No. 6/2002, with subsequent amendments. From the Minister of Health.
146 th Legislative session, 2016 2017. Parliamentary document x x. matter. Government bill. Bill amending the Tobacco Control Act, No. 6/2002, with subsequent amendments. From the Minister of Health. Article
More informationOpiate Freedom Center 1/11/18
Opiate Freedom Center 1/11/18 UNITED STATES OF AMERICA DEPARTMENT OF HEALTH FEDERAL TRADE COMMISSION AND HUMAN SERVICES BUREAU OF CONSUMER FOOD AND DRUG ADMINISTRATION PROTECTION SILVER SPRING, MD 20993
More informationMitch Zeller, Director, Center for Tobacco Products, FDA September 19, 2013 Kansas Public Health Association
Regulatory Public Laws Compliance & Education Policies Science & Enforcement & Communications The FDA Center for Tobacco Products (CTP): Its Role in Reducing Tobacco Use Mitch Zeller, Director, Center
More informationOpportunity Knocks: FDA/CDRH Medical Device Fellowship and External Expertise
Opportunity Knocks: FDA/CDRH Medical Device Fellowship and External Expertise Nancy J. Pluhowski Director, Office of the Center Director Center for Devices and Radiological Health (CDRH), FDA Stanford
More informationSharing Session Risk Factor Study Part II. September 14, 2017
Sharing Session Risk Factor Study Part II September 14, 2017 Housekeeping Items All lines will be muted during the entirety of the webinar. Throughout the presentation and during the discussion and Q&A
More informationInspections, Compliance, Enforcement, and Criminal Investigations
Page 1 of 5 Home Inspections, Compliance, Enforcement, and Criminal Investigations Enforcement Actions Warning Letters Inspections, Compliance, Enforcement, and Criminal Investigations V-SAB Medical Labs,
More information510(k) SUMMARY STATEMEMT. Mettler Traction Device, MTD 4000 OCT Mettler Electronics Corp South Claudina Street Anaheim, CA 92805
510(k) SUMMARY STATEMEMT OCT - 8 2009 Mettler Traction Device, MTD 4000 Submitter's Name: Address: Mettler Electronics Corp. 1333 South Claudina Street Anaheim, CA 92805 Telephone: 714-533-2221 x324 Fax:
More informationOn the use of Amalgam for dental fillings in Sweden
On the use of Amalgam for dental fillings in Sweden Director Medical Devices Medical Products Agency Uppsala, Sweden Content of this presentation Short regulatory introduction Current use of Amalgams in
More informationData retrieval using the new SMQ Medication Errors
Data retrieval using the new SMQ Medication Errors Christina Winter Medical Director Safety Evaluation and Risk Management, GSK Information Day on Medication Errors 20 October 2016 London, UK Disclaimer
More informationManaging Allergens within a manufacturing context. Helen Brown CampdenBRI Chipping Campden
Managing Allergens within a manufacturing context Helen Brown CampdenBRI Chipping Campden Food Allergens An unusual food safety issue Harmless natural substances however In allergic individuals cause reactions,
More informationHealth Authority Abu Dhabi. Document Title: Policy for Recall of Drugs and Healthcare Products Document Ref. Number:
Health Authority Abu Dhabi Document Title: Policy for Recall of Drugs and Healthcare Products Document Ref. Number: PPR/DMP/DR/P0001 Version 0.9 Approval Date: August 2007 Effective Date: August 2007 Last
More informationInspections, Compliance, Enforcement, and Criminal Investigations
Home Inspections, Compliance, Enforcement, and Criminal Investigations Enforcement Actions Warning Letters Inspections, Compliance, Enforcement, and Criminal Investigations Stanislaw R Burzynski, MD 12/3/13
More informationGeorge Misko is a Partner at Keller and Heckman LLP George joined Keller and Heckman in Mr. Misko's practice focuses on food and drug matters
George Misko is a Partner at Keller and Heckman LLP George joined Keller and Heckman in 1989. Mr. Misko's practice focuses on food and drug matters and environmental concerns, including pesticide regulation,
More informationRaritan Pharmaceuticals, Inc. 6/20/17
Raritan Pharmaceuticals, Inc. 6/20/17 U.S. Food & Drug Administration Division of Pharmaceutical Quality Operations I New Jersey District 10 Waterview Boulevard, 3rd Floor Parsippany, NJ 07054 June 20,
More informationSAS 112: Communicating Internal Control Related Matters Identified in an Audit
SAS 112: Communicating Internal Control Related Matters Identified in an Audit Effective: NOW!!! For audits of financial statements for periods ending on or after December 15, 2006. SAS 112 Requires the
More information